AR010304A1 - Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica - Google Patents
Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceuticaInfo
- Publication number
- AR010304A1 AR010304A1 ARP970105494A ARP970105494A AR010304A1 AR 010304 A1 AR010304 A1 AR 010304A1 AR P970105494 A ARP970105494 A AR P970105494A AR P970105494 A ARP970105494 A AR P970105494A AR 010304 A1 AR010304 A1 AR 010304A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenylpiperazin
- ethoxyphenyl
- cis
- dimesylate
- methylciclohexane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3181596P | 1996-11-26 | 1996-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR010304A1 true AR010304A1 (es) | 2000-06-07 |
Family
ID=21861551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970105494A AR010304A1 (es) | 1996-11-26 | 1997-11-24 | Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5914329A (https=) |
| EP (1) | EP0944611B1 (https=) |
| JP (1) | JP3120861B2 (https=) |
| AP (1) | AP9701148A0 (https=) |
| AR (1) | AR010304A1 (https=) |
| AT (1) | ATE257472T1 (https=) |
| AU (1) | AU4792497A (https=) |
| BR (1) | BR9713538A (https=) |
| CA (1) | CA2272927C (https=) |
| DE (1) | DE69727155T2 (https=) |
| DK (1) | DK0944611T3 (https=) |
| ES (1) | ES2213207T3 (https=) |
| GT (1) | GT199700123A (https=) |
| HN (1) | HN1997000154A (https=) |
| HR (1) | HRP970640A2 (https=) |
| ID (1) | ID18964A (https=) |
| MA (1) | MA26450A1 (https=) |
| PA (1) | PA8441701A1 (https=) |
| PE (1) | PE17099A1 (https=) |
| PT (1) | PT944611E (https=) |
| TN (1) | TNSN97191A1 (https=) |
| WO (1) | WO1998023603A1 (https=) |
| ZA (1) | ZA9710587B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001053477A1 (en) * | 2000-01-20 | 2001-07-26 | Baylor College Of Medicine | Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
| WO2003049673A2 (en) | 2001-12-05 | 2003-06-19 | Baylor College Of Medicine | Methods and compositions for control of bone formation via modulation of sympathetic tone |
| ATE321865T1 (de) | 2002-01-09 | 2006-04-15 | Arexis Ab | Mutationsnachweis |
| ES2333739T3 (es) * | 2004-11-23 | 2010-02-26 | Dong Wha Pharmaceutical Co., Ltd. | Sal de n-hidroxi-4-(5-(4-(5-isopropil-2-metil-1,3-tiazol-4-il)fenoxi) pentoxi)benzamidina con acido 2-metanosulfonico. |
| WO2006108218A1 (en) * | 2005-04-15 | 2006-10-19 | Regenertech Pty Limited | Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996014307A1 (en) * | 1994-11-07 | 1996-05-17 | Pfizer Inc. | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
-
1997
- 1997-11-18 PA PA19978441701A patent/PA8441701A1/es unknown
- 1997-11-18 US US08/972,470 patent/US5914329A/en not_active Expired - Fee Related
- 1997-11-19 AT AT97910602T patent/ATE257472T1/de not_active IP Right Cessation
- 1997-11-19 PE PE1997001052A patent/PE17099A1/es not_active Application Discontinuation
- 1997-11-19 JP JP10524469A patent/JP3120861B2/ja not_active Expired - Fee Related
- 1997-11-19 EP EP97910602A patent/EP0944611B1/en not_active Expired - Lifetime
- 1997-11-19 AU AU47924/97A patent/AU4792497A/en not_active Abandoned
- 1997-11-19 DK DK97910602T patent/DK0944611T3/da active
- 1997-11-19 DE DE69727155T patent/DE69727155T2/de not_active Expired - Fee Related
- 1997-11-19 ES ES97910602T patent/ES2213207T3/es not_active Expired - Lifetime
- 1997-11-19 PT PT97910602T patent/PT944611E/pt unknown
- 1997-11-19 WO PCT/IB1997/001465 patent/WO1998023603A1/en not_active Ceased
- 1997-11-19 CA CA002272927A patent/CA2272927C/en not_active Expired - Fee Related
- 1997-11-19 BR BR9713538A patent/BR9713538A/pt not_active Application Discontinuation
- 1997-11-20 AP APAP/P/1997/001148A patent/AP9701148A0/en unknown
- 1997-11-24 AR ARP970105494A patent/AR010304A1/es unknown
- 1997-11-25 TN TNTNSN97191A patent/TNSN97191A1/fr unknown
- 1997-11-25 ZA ZA9710587A patent/ZA9710587B/xx unknown
- 1997-11-25 MA MA24872A patent/MA26450A1/fr unknown
- 1997-11-25 ID IDP973762A patent/ID18964A/id unknown
- 1997-11-25 GT GT199700123A patent/GT199700123A/es unknown
- 1997-11-26 HR HR60/031,815A patent/HRP970640A2/hr not_active Application Discontinuation
- 1997-11-26 HN HN1997000154A patent/HN1997000154A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3120861B2 (ja) | 2000-12-25 |
| EP0944611A1 (en) | 1999-09-29 |
| JP2000505110A (ja) | 2000-04-25 |
| MA26450A1 (fr) | 2004-12-20 |
| GT199700123A (es) | 1999-05-19 |
| ID18964A (id) | 1998-05-28 |
| PT944611E (pt) | 2004-04-30 |
| PA8441701A1 (es) | 2000-05-24 |
| DE69727155T2 (de) | 2004-07-08 |
| US5914329A (en) | 1999-06-22 |
| WO1998023603A1 (en) | 1998-06-04 |
| PE17099A1 (es) | 1999-02-19 |
| EP0944611B1 (en) | 2004-01-07 |
| DE69727155D1 (de) | 2004-02-12 |
| CA2272927C (en) | 2003-02-04 |
| DK0944611T3 (da) | 2004-04-13 |
| AU4792497A (en) | 1998-06-22 |
| BR9713538A (https=) | 2000-03-21 |
| TNSN97191A1 (fr) | 2005-03-15 |
| ZA9710587B (en) | 1999-05-25 |
| CA2272927A1 (en) | 1998-06-04 |
| ES2213207T3 (es) | 2004-08-16 |
| AP9701148A0 (en) | 1998-01-31 |
| HRP970640A2 (en) | 1998-10-31 |
| ATE257472T1 (de) | 2004-01-15 |
| HN1997000154A (es) | 1999-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9506305A (pt) | Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo | |
| PT800519E (pt) | Compostos moduladores de receptores de esteroides e metodos | |
| ATE234092T1 (de) | 2-alkylpyrrolidine | |
| PT804196E (pt) | Utilizacao de antagonistas de serotonina (5ht3) para o tratamento de fibromialgia | |
| EA199800667A1 (ru) | Новые фенантридины | |
| ATE211743T1 (de) | Substituierte 3-aminochinuclidine | |
| NO986100D0 (no) | Androgene reseptormodulerende forbindelser og fremgangsmÕter | |
| BR0206985A (pt) | Anticorpos modificados e métodos de uso | |
| SE8503680D0 (sv) | Indolderivat | |
| UY26130A1 (es) | Compuestos para tratar la obesidad | |
| MY8400018A (en) | Substituted propanolamine and morpholine derivatives | |
| BR0015416A (pt) | Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos | |
| MX9704037A (es) | 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos. | |
| ES2194918T3 (es) | Compuestos de tiazol y tiadiazol como ligando receptor de dopamina d3. | |
| DE69801660D1 (de) | Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8 | |
| EA199900912A1 (ru) | Фармацевтические средства | |
| BR9910329A (pt) | Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto | |
| ES525737A0 (es) | Un procedimiento para la preparacion de nuevas idolonas. | |
| FR2581382B1 (fr) | Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes | |
| AR010304A1 (es) | Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica | |
| MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
| ES2103825T3 (es) | Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales. | |
| DK1342410T3 (da) | Anvendelse af en galaninagonist til fremstilling af et medikament til forbedring af hukommelse og andre kognitive funktioner | |
| BR9508021A (pt) | Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico | |
| AR008154A1 (es) | Acido (s)-7-[(4,4'-bipiperidin-1-il)carbonil]-2,3,4,5-tetrahidro-4-metil- -3-oxo-1h-1,4-benzodiazepina-2-acetico, como hidrocloruro del mismo, unacomposicion farmaceutica que lo comprende, el uso del mismo y un procedimiento para su preparacion. |